Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
about
Cancer-Related Functions and Subcellular Localizations of SeptinsSeptin Mutations in Human CancersA Computational Methodology to Overcome the Challenges Associated With the Search for Specific Enzyme Targets to Develop Drugs Against Leishmania major.Proteomic profile of pre - B2 lymphoblasts from children with acute lymphoblastic leukemia (ALL) in relation with the translocation (12; 21)High SEPT9_i1 protein expression is associated with high-grade prostate cancersSeptin functions in organ system physiology and pathology.Septin cooperation with tubulin polyglutamylation contributes to cancer cell adaptation to taxanesNovel septin 9 repeat motifs altered in neuralgic amyotrophy bind and bundle microtubules.High throughput screening of natural products for anti-mitotic effects in MDA-MB-231 human breast carcinoma cellsGenome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stress.Gene isoforms as expression-based biomarkers predictive of drug response in vitro.
P2860
Q28076836-38EF30FF-0187-4476-AC36-899C93831FA0Q28078227-CAC5F1F7-D69F-4EAC-A375-4E3461C79D8BQ33797941-4FE3D4D4-3C24-4504-927B-4C8C8CCD0C4BQ34027272-352B5560-F115-4588-B1E2-478460503F03Q35610801-B6E66352-F0F3-4BC6-9A57-257399F36B24Q35673813-BC2E49AB-A7CF-4FAF-BAEE-45991FC88ACDQ36546567-5704C40B-7301-4091-84E1-7480BDBB7740Q37411028-B1FBC58B-EAAF-43EF-8821-55DBD4F7813AQ37641834-050A3E73-B7F4-4712-8333-8D6674111D90Q40165187-272EAD65-7E40-4E95-8B4F-22CD0413BE34Q42635307-CAE5A293-145B-428F-A429-66A64E45D55A
P2860
Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
@en
Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
@nl
type
label
Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
@en
Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
@nl
prefLabel
Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
@en
Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
@nl
P2093
P2860
P1433
P1476
Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
@en
P2093
Alex D Chacko
John Price
Peter A Hall
Richard Kennedy
S E Hilary Russell
Severine Chanduloy
Stewart W Church
P2860
P2888
P356
10.1007/S13402-011-0066-0
P577
2012-01-26T00:00:00Z